Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.62 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 2/20 | 0.54 |
| ▸ | CES1 | P23141 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28193245 | 0.93 | MAPT (0.69) | MAPTSMN1; SMN2HSD17B1KMT2AMEN1 | |
| SCHEMBL17187946 | 0.93 | MAPT (0.69) | MAPTSMN1; SMN2HSD17B1KMT2AMEN1 | |
| SCHEMBL75640 | 0.93 | MAPT (0.69) | MAPTSMN1; SMN2HSD17B1KMT2AMEN1 | |
| Ammonia Solution, Strong SCHEMBL17180520 | 0.90 | MAPT (0.67) | MAPTSMN1; SMN2HSD17B1KMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL27858043 | 0.90 | MAPT (0.67) | MAPTSMN1; SMN2HSD17B1KMT2AMEN1 | |
| Nitrogen SCHEMBL27858242 | 0.88 | MAPT (0.64) | MAPTSMN1; SMN2HSD17B1KMT2AMEN1 | |
| SCHEMBL197130 | 0.87 | MAPT (0.80) | MAPTSMN1; SMN2HSD17B1KMT2ARAB9A | |
| SCHEMBL11441494 | 0.87 | MAPT (0.80) | MAPTSMN1; SMN2HSD17B1KMT2ARAB9A | |
| Carbon Monoxide SCHEMBL10625076 | 0.86 | MAPT (0.62) | MAPTSMN1; SMN2HSD17B1KMT2AMEN1 | |
| SCHEMBL31186097 | 0.86 | SRD5A2 (0.64) | MAPTSMN1; SMN2KMT2AMEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4573086-A1 | METHANOGEN INHIBITORS | Agrizeronz Limited Partnership (NZ) | 2025-06-25 | — | — | EP | disclosed |
| CN-119998272-A | Methanogen inhibitors | 阿格里泽伦茨有限合伙公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-113825735-B | Carbon-carbon bond formation method | 奥加诺株式会社 | 2025-01-07 | — | — | CN | disclosed |
| WO-2024039250-A1 | METHANOGEN INHIBITORS | PASTORAL GREENHOUSE GAS RESEARCH LIMITED (NZ) | 2024-02-22 | — | — | WO | disclosed |
| US-20220168723-A1 | METHOD FOR FORMING CARBON-CARBON BOND | ORGANO CORPORATION (JP) | 2022-06-02 | — | — | US | disclosed |
| US-20220168723-A1 | METHOD FOR FORMING CARBON-CARBON BOND | ORGANO CORPORATION (JP) | 2022-06-02 | — | — | US | disclosed |
| EP-3971156-A1 | METHOD FOR FORMING CARBON-CARBON BOND | Organo Corporation (JP) | 2022-03-23 | — | — | EP | disclosed |
| US-20220024980-A1 | LIPO-GLYCOPEPTIDE CLEAVABLE DERIVATIVES AND USES THEREOF | BIOPHARMA CREDIT PLC (GB) | 2022-01-27 | — | — | US | disclosed |
| CN-113825735-A | Method for forming carbon-carbon bond | 奥加诺株式会社 | 2021-12-21 | — | — | CN | disclosed |
| EP-3587406-B1 | 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER | FORMA THERAPEUTICS INC (US) | 2021-01-27 | — | — | EP | disclosed |
| US-6649619-B1 | 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl) benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimeth ylenepyrimidin-4-one or salt; lipoprotein-associated phospholipase A inhibitors | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-11-18 | — | — | US | disclosed |
| WO-2003082852-A1 | NOVEL SUBSTITUTED 1,2,4-TRIOXANES USEFUL AS ANTIMALARIAL AGENTS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-09 | — | — | WO | disclosed |
| WO-2003027085-A2 | 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS | BAYER PHARMACEUTICALS CORPORATION (US) | 2003-04-03 | — | — | WO | disclosed |
| CN-1082023-A | The medicine and the novel benzoic acid derivative that contain benzoic acid derivative | YAMANOUCHI PHARMA CO LTD (JP) | 1994-02-16 | — | — | CN | disclosed |
| US-4239759-A | Morpholino containing compounds, compositions and use thereof | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1980-12-16 | — | — | US | disclosed |
| US-4125612-A | N-1-(p-Biphenylalkyl)piperazines and their use as anti-inflammatory agents | SCHERING CORPORATION (US) | 1978-11-14 | — | — | US | disclosed |
| US-4110447-A | Anti-inflammatory (halo-4-biphenylyl)-alkanolamines | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1978-08-29 | — | — | US | disclosed |
| US-4027041-A | Ethyl- and vinylbenzenes as antithrombotic agents | ELI LILLY AND COMPANY (US) | 1977-05-31 | — | — | US | disclosed |
| US-4024284-A | Ethyl- and vinylbenzenes as anti-inflammatory agents | ELI LILLY AND COMPANY (US) | 1977-05-17 | — | — | US | disclosed |
| US-3975542-A | Ethyl- and vinylbenzenes as antithromobiotic agents | ELI LILLY AND COMPANY (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220024980-A1 | LIPO-GLYCOPEPTIDE CLEAVABLE DERIVATIVES AND USES THEREOF | PGLS, LGALS3BP, LNPEP | MAPT 4457/4885SMN1; SMN2 4822/4885HSD17B1 2436/4885 |
| US-20220168723-A1 | METHOD FOR FORMING CARBON-CARBON BOND | SLC40A1, SLCO4C1, NUP93 | MAPT 3193/4885SMN1; SMN2 3496/4885HSD17B1 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.